A recent study led by scientists at the UK DRI and Neuroscience and Mental Health Innovation Institute at Cardiff University has revealed that smartwatches hold the potential to detect Parkinson’s disease up to seven years before the emergence of hallmark symptoms.

The researchers studied data obtained from 103,712 UK Biobank participants who wore a medical-grade smartwatch for a week between 2013 and 2016.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

This meant that speed of movement and average acceleration had been measured by the devices continuously for the week.

The researchers compared data from two groups, including one consisting of participants already diagnosed with Parkinson’s disease.

Another group comprised individuals who received their diagnosis up to seven years after the collection of smartwatch data.

The data was analysed to measure the participants’ movement speed over a span of seven days.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Scientists found that smartwatches utilising artificial intelligence can precisely predict individuals who are likely to develop Parkinson’s disease in the future.

According to researchers, smartwatches can serve as a new screening tool for Parkinson’s disease by allowing the disorder detection at a much earlier stage than existing methods.

UK DRI at Cardiff emerging leader and study leader Dr Cynthia Sandor said: “We have shown here that a single week of data captured can predict events up to seven years in the future.

“With these results, we could develop a valuable screening tool to aid in the early detection of Parkinson’s.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact